CAS: 66788-41-8; (1R,2S)-2-[3,3-Di(Thiophen-3-yl)Prop-2-Enylamino]-1-Phenylpropan-1-Ol

📜3-[[(1R,2S)-1-Hydroxy-1-Phenylpropan-2-Yl]Amino]-1,1-Di(Thiophen-3-yl)Propan-1-Ol,盐酸 以51%的收率获得产物
参考文献:Kleemann,A.;Heese,J.;Engel,J.,Arzneimittel-Forsch.,1981,31,N 8,1178-1183
标题:Kleemann,A.;Heese,J.;Engel,J.,Arzneimittel-Forsch.,1981,31,N 8,1178-1183

专利信息

专利号:US-2008287407-A1
优先权日:2003-12-10
标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
发明人：GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
权利人:NITROMED INC
摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.